-
Trump Signals Willingness to Work With Democrats After Midterm Defeat
-
Abdul El-Sayed Wins Michigan Senate Seat in Historic Election
-
Qatar media bodies discuss support for humanitarian initiatives
-
Galloway accuser could not foresee publishing-sector fallout, lawyer argues
-
No. 22 UCLA defeats No. 5 Arizona 84-75 despite Kharchenkov's 38 points
-
New York City Center revives In the Heights as a timely community story
-
Vessel operator seeks witnesses after Vancouver grounding
-
Godzilla Minus Zero shifts focus toward postwar human drama
-
US Air Force deploys F-16 fighters to remote Aleutian base for readiness drill
-
Mehbooba Mufti urges dialogue and renewed Central Asia links for Kashmir
-
Bezos grant helps Seattle nonprofit move thousands of families toward housing
-
Seacliff Healthcare Seeks Specialist GP in Thirroul
-
Shrini Srivastava joins crew of Varanasi-Delhi Vande Bharat Sleeper service
-
US stocks fall before midterm Election Day as technology shares weaken
-
Nearly Half of Australian Workers Overqualified, Survey Finds
-
BLS Polymers makes strong market debut at ₹248 per share
-
RBI eases export-declaration compliance for individual service exporters
-
Petrol and diesel prices remain broadly steady across major Indian cities
-
India proposes more import entry points for drugs and medical devices
-
Reliance shares remain in focus after near-12% surge
-
Derek Tierney Outlines Ten-Year Strategy for National Digital Health System
-
2026 Arizona Midterms: Key Races, Ballot Measures, and Voter Deadlines
-
NBC’s Steve Kornacki Reveals Tech Habits Ahead of Midterm Elections
-
Coal India prepares possible $1 billion Mahanadi Coalfields listing
-
India and Israel oppose UN draft on regional conventional arms control
-
Julia Stiles and Ezra Sosa Share Emotional Farewell After 'DWTS' Elimination
-
BLS Polymers shares open 65.3% above IPO price
-
US Buildings Threatened by Wildfires Could Triple by 2060
-
Capital-markets shares rally as Motilal Oswal and Angel One lead gains
-
Why Pregnancy Cost Estimates Fail: A Family’s $9,000 Surprise
-
Latino Voters Defy ICE Fears, Turn Out in Record Numbers for Midterms
-
US Strikes Iranian Targets in Strait of Hormuz Ahead of Midterms
-
ITC shares rise as analysts anticipate gradual cigarette-business recovery
-
Brodeur’s Overtime Goal Secures Bethlehem’s Second Consecutive Sectional Title
-
Reliance rally puts historical one-year return pattern in focus
-
Rare 1970 Plymouth ‘Cuda 426 Hemi Listed for $400,000
-
Kuwait edges Oman 1-0 in veterans Gulf Cup in Doha
-
The Digital Burden: Why Instant Messaging Feels Like a Full-Time Job
-
Saudi Aramco quarterly profit climbs 34.6% amid elevated oil prices
Retired NBA legend Dikembe Mutombo battling brain tumor
NBA Hall of Famer Dikembe Mutombo, one of the best defenders in the league's history, is undergoing treatment for a brain tumor, the league announced Saturday.
Mutombo, 56, hails from the Democratic Republic of Congo, and has been a global ambassador for the National Basketball Association for years.
He played for several teams throughout his long career, including the Denver Nuggets, the Philadelphia 76ers, the Atlanta Hawks and the then New Jersey Nets.
"Dikembe Mutombo is currently undergoing treatment for a brain tumor," the NBA said in a statement issued on behalf of Mutombo's family.
"He is receiving the best care possible from a collaborative team of specialists in Atlanta and is in great spirits as he begins treatment," the statement said.
"Dikembe and his family ask for privacy during this time so they can focus on his care. They are grateful for your prayers and good wishes."
The eight-time NBA All-Star is second all-time in the league for blocked shots, behind Hakeem Olajuwon.
Before his pro career, he was a standout for the Georgetown University Hoyas.
C.Meier--BTB